Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

被引：0
|
作者：
T Iwasa
I Okamoto
K Takezawa
K Yamanaka
T Nakahara
A Kita
H Koutoku
M Sasamata
E Hatashita
Y Yamada
K Kuwata
M Fukuoka
K Nakagawa
机构：
[1] Kinki University School of Medicine,Department of Medical Oncology
[2] 377-2 Ohno-higashi,Department of Medical Oncology
[3] Osaka-Sayama,undefined
[4] Osaka 589-8511,undefined
[5] Japan,undefined
[6] Institute of Drug Discovery Research,undefined
[7] Astellas Pharma Inc.,undefined
[8] 21 Miyukigaoka,undefined
[9] Tsukuba-shi,undefined
[10] Ibaraki 305-8585,undefined
[11] Japan,undefined
[12] Kinki University School of Medicine,undefined
[13] Sakai Hospital,undefined
[14] 2-7-1 Harayamadai,undefined
[15] Minami-ku Sakai,undefined
[16] Osaka 590-0132,undefined
[17] Japan,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
survivin; YM155; apoptosis; DNA repair; non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：36 / 42
页数：6
相关论文
共 50 条
  • [1] Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
    Iwasa, T.
    Okamoto, I.
    Takezawa, K.
    Yamanaka, K.
    Nakahara, T.
    Kita, A.
    Koutoku, H.
    Sasamata, M.
    Hatashita, E.
    Yamada, Y.
    Kuwata, K.
    Fukuoka, M.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2010, 103 (01) : 36 - 42
  • [2] Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma
    Yu, Ying
    Zhao, Xiaosu
    Zhang, Yu
    Kang, Yanling
    Wang, Jiaqi
    Liu, Yingchun
    ONCOLOGY REPORTS, 2015, 34 (01) : 407 - 414
  • [3] YM155, a novel survivin suppressant, demonstrates activity in subjects with stage III or IV melanoma
    Gonzalez, R.
    Samlowski, W.
    Cranmer, L.
    Catlett, J.
    Whitman, E.
    Lawson, D.
    Lewis, K.
    Drake, T.
    Bartels, P.
    Buell, D.
    Keating, A.
    Kirkwood, J.
    ANNALS OF ONCOLOGY, 2007, 18 : 40 - 40
  • [4] MEDI 312-Discovery of YM155, a novel survivin suppressant for the treatment of cancer
    Kinoyama, Isao
    Matsuhisa, Akira
    Nakahara, Takahito
    Takeuchi, Masahiro
    Shirasuna, Kenna
    Minematsu, Tsuyoshi
    Asai, Norio
    Matsumoto, Shunichiro
    Kawaguchi, Kenichi
    Kazami, Junichi
    Toyoshima, Akira
    Kita, Aya
    Tominaga, Fumiko
    Okada, Minoru
    Ohta, Mitsuaki
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [5] Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
    Satoh, Taroh
    Okamoto, Isamu
    Miyazaki, Masaki
    Morinaga, Ryotaroh
    Tsuya, Asuka
    Hasegawa, Yoshikazu
    Terashima, Masaaki
    Ueda, Shinya
    Fukuoka, Masahiro
    Ariyoshi, Yutaka
    Saito, Toshikazu
    Masuda, Noriyuki
    Watanabe, Hirokazu
    Taguchi, Tetsuo
    Kakihara, Toru
    Aoyama, Yumiko
    Hashimoto, Yohko
    Nakagawa, Kazuhiko
    CLINICAL CANCER RESEARCH, 2009, 15 (11) : 3872 - 3880
  • [6] Carrier-mediated uptake of YM155, a novel survivin suppressant, into human cancer cells in vitro
    Minematsu, Tsuyoshi
    Iwai, Megumi
    Nakahara, Takahito
    Usui, Takashi
    Kamimura, Hidetaka
    DRUG METABOLISM REVIEWS, 2006, 38 : 112 - 112
  • [7] Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia
    Chen, Jing
    Pise-Masison, Cynthia A.
    Shih, Joanna H.
    Morris, John C.
    Janik, John E.
    Conlon, Kevin C.
    Keating, Anne
    Waldmann, Thomas A.
    BLOOD, 2013, 121 (11) : 2029 - 2037
  • [8] Involvement of Multidrug Resistance 1 (MDR1) for the Pharmacokinetics of YM155, a Novel Survivin Suppressant
    Iwai, Megumi
    Minematsu, Tsuyoshi
    Li, Qun
    Iwatsubo, Takafumi
    Usui, Takashi
    DRUG METABOLISM REVIEWS, 2010, 42 : 288 - 289
  • [9] METABOLISM OF YM155 MONOBROMIDE, A NOVEL SURVIVIN SUPPRESSANT: IN VITRO SPECIES COMPARISON AND IDENTIFICATION OF METABOLITES IN RATS
    Sohda, Kin-ya
    Suzuki, Katsuhiro
    Nakamura, Eiji
    Minematsu, Tsuyoshi
    Hashimoto, Tadashi
    Imai, Harumitsu
    Usui, Takashi
    Kawamura, Akio
    Kamimura, Hidetaka
    DRUG METABOLISM REVIEWS, 2007, 39 : 253 - 254
  • [10] HUMAN ORGANIC CATION TRANSPORTER 1-MEDIATED TRANSPORT OF YM155, A NOVEL SURVIVIN SUPPRESSANT
    Minematsu, Tsuyoshi
    Iwai, Megumi
    Umehara, Ken-ichi
    Usui, Takashi
    Kamimura, Hidetaka
    DRUG METABOLISM REVIEWS, 2007, 39 : 67 - 68
12345